Latest News

Heading 1

with a request body that specifies how to map the columns of your import file to the associated CRM properties in HubSpot.... In the request JSON, define the import file details, including mapping the spreadsheet's columns to HubSpot data. Your request JSON should include the following fields:... entry for each column.

Heading 1

with a request body that specifies how to map the columns of your import file to the associated CRM properties in HubSpot.... In the request JSON, define the import file details, including mapping the spreadsheet's columns to HubSpot data. Your request JSON should include the following fields:... entry for each column.

Treatments

Balancing Benefit, Risk, and Access to VYKAT XR
As the PWS community gains more real-world experience with VYKAT XR, important conversations are taking place about how to balance the medication’s potential benefits with known risks. FPWR believes both deserve careful consideration. Recent reports of 7 deaths and more
Modafinil and Daytime Sleepiness in Prader-Willi Syndrome
Modafinil and Daytime Sleepiness in Prader-Willi Syndrome
Excessive daytime sleepiness (EDS) is one of those symptoms of Prader-Willi syndrome (PWS) that often does not get the attention it deserves. EDS can profoundly undermine success in older children and adults with PWS. It is hard to learn anything
Are GLP-1s Safe and Effective for People with PWS?
You have probably heard of GLP-1 receptor agonists (GLP-1s). You may even know someone who has successfully lost weight using one of these popular medications. But what about their safety and effectiveness for people with Prader-Willi syndrome (PWS)? GLP-1s are
Recent Publications Explore Pitolisant as a Treatment  for Daytime Sleepiness in PWS
Pitolisant for Daytime Sleepiness in PWS: New Research Findings
Families and caregivers in the Prader-Willi syndrome (PWS) community whose loved one experiences excessive daytime sleepiness (EDS) know just how challenging it can be in daily life. Data from the Global PWS Registry show that 55% of participants experience significant
5 Treatments to Improve Quality of Life for People with PWS
FPWR is dedicated to advancing research and accelerating the development of safe and effective treatments for people with Prader-Willi syndrome (PWS). While significant unmet needs remain, there are several therapies—both established and emerging—that can positively impact health and quality of
Research news graphic about guanfacine and behavioral challenges in Prader-Willi syndrome
Guanfacine (GXR) Shows Promise for Managing Aggression in PWS
A published study on the use of guanfacine extended release (GXR) in individuals with Prader-Willi syndrome (PWS) marks an important step forward, showing that guanfacine can improve challenging PWS behaviors, including aggression, skin-picking, and hyperactivity. Funded by FPWR, this was
Long-Term Safety and Benefits of Growth Hormone Therapy for PWS
Research supports the benefits of growth hormone (GH) therapy for people with PWS, with more than two decades of research and clinical experience providing reassuring evidence of safety. Like any treatment, GH requires appropriate screening and monitoring, particularly for health

Subscribe to hope.

If you're looking for the latest information on Prader-Willi syndrome, you’ve come to the right place. FPWR Updates is your source for up-to-date information.

Heading 1

with a request body that specifies how to map the columns of your import file to the associated CRM properties in HubSpot.... In the request JSON, define the import file details, including mapping the spreadsheet's columns to HubSpot data. Your request JSON should include the following fields:... entry for each column.

Evan and Dr. Fallah